The Juvenile Diabetes Research Foundation has announced a partnership with Osiris Therapeutics, Inc. (NASDAQ:OSIR) to support a Phase II clinical trial using Prochymal, an immunomodulatory cell therapy product, to preserve and regenerate insulin-producing cells in patients newly diagnosed with type 1 diabetes . [click link for full article]
Read More...
[Source: Yahoo! News Search Results for Diabetes for young people]
Why this Blog?
Shortly after my 12 year old nephew was diagnosed with Diabetes 1, I started this blog for he and his mother. There is so much to learn and so much to know and so many unanswered questions. My hope is that it provides a place for knowledge and healing. To your health nephew!
Love Always-
Hannah
Love Always-
Hannah
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment